In both in vivo and in vitro model of cerebral ischemia, combining HDAC inhibitors with very low doses of resveratrol exerted synergistic neuroprotective effects, significantly prolonging neuroprotection (Lanzillotta et al., 2013). This evidence concerns the gene HDAC9 and brain ischemia.